Oligonucleotide-based Medicines (OBMs)
Therapeutic drugs composed of short nucleotide sequences engineered to modify gene transcription or translation.
Source: Deep Tech Opportunities Report 2023 (DCVC (Data Collective)) · p.34
Have a question about Oligonucleotide-based Medicines (OBMs)? Ask the AI, answers cite the source.